CIK: 0001595851 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value: $303M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SER TR | 300,000 | $24.96M | 8.2% | $83.20 | — | — | Call | 78464A870 |
| TGTX | TG THERAPEUTICS INC | 825,000 | $20.49M | 6.8% | $24.84 * | $15.19 | +70.0% | COM | 88322Q108 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 330,000 | $16.83M | 5.6% | $51.00 * | $20.94 | +28.5% | CLASS A ORD | 61559X104 |
| — | AKERO THERAPEUTICS INC | 360,000 | $16.81M | 5.5% | $46.69 | $44.16 | — | COM | 00973Y108 |
| APLS | APELLIS PHARMACEUTICALS INC | 180,000 | $16.4M | 5.4% | $91.10 * | $54.54 | +58.2% | COM | 03753U106 |
| PCVX | VAXCYTE INC | 280,000 | $13.98M | 4.6% | $49.94 * | $31.83 | +48.9% | COM | 92243G108 |
| — | REVANCE THERAPEUTICS INC | 525,000 | $13.29M | 4.4% | $25.31 | $26.11 | — | COM | 761330109 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 55,000 | $12.71M | 4.2% | $231.00 * | $197.92 | +36.8% | COM | 558868105 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 550,000 | $11.86M | 3.9% | $21.57 * | $27.45 | -1.6% | COM | 03237H101 |
| VKTX | VIKING THERAPEUTICS INC | 650,000 | $10.54M | 3.5% | $16.21 * | $8.44 | +148.3% | COM | 92686J106 |
| SRPT | SAREPTA THERAPEUTICS INC | 85,000 | $9.734M | 3.2% | $114.52 * | $96.08 | +34.1% | COM | 803607100 |
| ASND | ASCENDIS PHARMA A/S | 100,000 | $8.925M | 2.9% | $89.25 | $124.74 | — | SPONSORED ADR | 04351P101 |
| — | REATA PHARMACEUTICALS INC | 85,000 | $8.667M | 2.9% | $101.96 | $38.69 | — | CL A | 75615P103 |
| AXSM | AXSOME THERAPEUTICS INC | 110,000 | $7.905M | 2.6% | $71.86 * | $36.01 | +104.8% | COM | 05464T104 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 350,000 | $7.325M | 2.4% | $20.93 | $21.73 | -4.2% | COM | 87164F105 |
| — | MIRATI THERAPEUTICS INC | 200,000 | $7.226M | 2.4% | $36.13 | $58.72 | — | COM | 60468T105 |
| XENE | XENON PHARMACEUTICALS INC | 185,000 | $7.122M | 2.4% | $38.50 * | $36.94 | +7.6% | COM | 98420N105 |
| COGT | COGENT BIOSCIENCES INC | 575,000 | $6.808M | 2.2% | $11.84 * | $10.88 | +5.4% | COM | 19240Q201 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 225,000 | $6.215M | 2.1% | $27.62 * | $16.79 | +49.0% | COM | 74366E102 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 240,000 | $5.71M | 1.9% | $23.79 * | $20.24 | +26.7% | COM | 92790C104 |
| BMEA | BIOMEA FUSION INC | 190,000 | $4.17M | 1.4% | $21.95 * | $19.38 | +61.5% | COM | 09077A106 |
| INCY | INCYTE CORP | 65,000 | $4.046M | 1.3% | $62.25 * | $78.23 | -14.6% | COM | 45337C102 |
| ONC | BEIGENE LTD | 22,500 | $4.012M | 1.3% | $178.30 | $178.30 | — | SPONSORED ADR | 07725L102 |
| — | AMBRX BIOPHARMA INC | 238,225 | $3.921M | 1.3% | $16.46 | $8.92 | — | SPONSORED ADS | 02290A102 |
| VIR | VIR BIOTECHNOLOGY INC | 150,000 | $3.679M | 1.2% | $24.53 * | $25.11 | 0.0% | COM | 92764N102 |
| — | ALPINE IMMUNE SCIENCES INC | 347,432 | $3.572M | 1.2% | $10.28 | $8.81 | — | COM | 02083G100 |
| — | AEROVATE THERAPEUTICS INC | 201,197 | $3.451M | 1.1% | $17.15 | $17.75 | — | COM | 008064107 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 100,000 | $2.821M | 0.9% | $28.21 * | $23.99 | 0.0% | COM | 98943L107 |
| — | KARUNA THERAPEUTICS INC | 12,500 | $2.711M | 0.9% | $216.85 | $144.21 | — | COM | 48576A100 |
| TARS | TARSUS PHARMACEUTICALS INC | 150,000 | $2.711M | 0.9% | $18.07 * | $24.08 | -34.0% | COM | 87650L103 |
| FOLD | AMICUS THERAPEUTICS INC | 200,000 | $2.512M | 0.8% | $12.56 * | $12.33 | -3.7% | COM | 03152W109 |
| — | ASTRIA THERAPEUTICS INC | 300,173 | $2.5M | 0.8% | $8.33 | $9.04 | — | COM | 04635X102 |
| QURE | UNIQURE NV | 215,000 | $2.464M | 0.8% | $11.46 * | $20.98 | -9.7% | SHS | N90064101 |
| KRYS | KRYSTAL BIOTECH INC | 20,000 | $2.348M | 0.8% | $117.40 * | $102.10 | 0.0% | COM | 501147102 |
| — | VERONA PHARMA PLC | 110,000 | $2.325M | 0.8% | $21.14 | $21.14 | — | SPONSORED ADS | 925050106 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 154,250 | $2.209M | 0.7% | $14.32 * | $11.53 | 0.0% | COM | 71722W107 |
| — | FUSION PHARMACEUTICALS INC | 412,699 | $1.927M | 0.6% | $4.67 | $3.91 | — | COM | 36118A100 |
| — | IMMUNOGEN INC | 100,000 | $1.887M | 0.6% | $18.87 | $3.84 | — | COM | 45253H101 |
| PMVP | PMV PHARMACEUTICALS INC | 280,981 | $1.759M | 0.6% | $6.26 * | $5.24 | 0.0% | COM | 69353Y103 |
| WHWK | AADI BIOSCIENCE INC | 250,000 | $1.71M | 0.6% | $6.84 * | $13.64 | -43.0% | COM | 00032Q104 |
| RCUS | ARCUS BIOSCIENCES INC | 75,000 | $1.523M | 0.5% | $20.31 * | $19.11 | -0.4% | COM | 03969F109 |
| RCKT | ROCKET PHARMACEUTICALS INC | 75,000 | $1.49M | 0.5% | $19.87 | $20.20 | 0.0% | COM | 77313F106 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 200,000 | $1.408M | 0.5% | $7.04 * | $13.89 | -42.2% | COM | 09058V103 |
| — | MORPHIC HLDG INC | 20,000 | $1.147M | 0.4% | $57.33 | $57.33 | — | COM | 61775R105 |
| — | INHIBRX INC | 35,000 | $909K | 0.3% | $25.96 | $25.96 | — | COM | 45720L107 |
| — | BIOXCEL THERAPEUTICS INC | 130,000 | $866K | 0.3% | $6.66 | — | — | Call | 09075P105 |
| — | SPRINGWORKS THERAPEUTICS INC | 27,578 | $723K | 0.2% | $26.22 | $25.75 | — | COM | 85205L107 |
| BBIO | BRIDGEBIO PHARMA INC | 42,000 | $722K | 0.2% | $17.20 * | $13.03 | +15.5% | COM | 10806X102 |
| RNAM | AVIDITY BIOSCIENCES INC | 65,000 | $721K | 0.2% | $11.09 * | $16.33 | -23.2% | COM | 05370A108 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 100,000 | $704K | 0.2% | $7.04 | $7.81 | -8.3% | COM | 462260100 |
| PTCT | PTC THERAPEUTICS INC | 16,675 | $678K | 0.2% | $40.67 * | $48.93 | 0.0% | COM | 69366J200 |
| ROIV | ROIVANT SCIENCES LTD | 64,000 | $645K | 0.2% | $10.08 * | $8.94 | 0.0% | SHS | G76279101 |
| — | RAIN ONCOLOGY INC | 325,000 | $390K | 0.1% | $1.20 | $7.00 | — | COM | 75082Q105 |
| REPL | REPLIMUNE GROUP INC | 10,865 | $252K | 0.1% | $23.22 * | $19.54 | 0.0% | COM | 76029N106 |
| VNDA | VANDA PHARMACEUTICALS INC | 31,000 | $204K | 0.1% | $6.59 * | $6.66 | -3.8% | COM | 921659108 |
| — | MERSANA THERAPEUTICS INC | 61,250 | $202K | 0.1% | $3.29 | $3.29 | — | COM | 59045L106 |
| — | FIBROGEN INC | 36,500 | $98,550 | 0.0% | $2.70 | $14.27 | — | COM | 31572Q808 |